Federal Register: November 28, 2008 (Volume 73, Number 230)
DOCID: fr28no08-89 FR Doc E8-28382
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket ID: [Docket No. FDA-2008-N-0578]
NOTICE: NOTICES
DOCID: fr28no08-89
ACTION: Meetings:
DOCUMENT ACTION: Notice.
SUBJECT CATEGORY:
Pediatric Ethics Subcommittee; Amendment of Notice
DOCUMENT SUMMARY:
The Food and Drug Administration (FDA) is announcing an amendment
to the notice of meeting of the Pediatric Ethics Subcommittee of the Pediatric Advisory Committee. This meeting was
[[Page 72494]]
announced in the Federal Register of November 14, 2008 (73 FR 67525).
The amendment is being made to reflect a change in the Procedure
portion of the document. There are no other changes.
SUMMARY:
Pediatric Ethics Subcommittee; Amendment,
DOCUMENT BODY:
The Food and Drug Administration (FDA) is announcing an amendment
to the notice of meeting of the Pediatric Ethics Subcommittee of the Pediatric Advisory Committee. This meeting was
[[Page 72494]]
announced in the Federal Register of November 14, 2008 (73 FR 67525).
The amendment is being made to reflect a change in the Procedure
portion of the document. There are no other changes.
SUPPLEMENTAL INFORMATION
In the Federal Register of November 14, 2008, FDA announced that a meeting of the Pediatric Ethics Subcommittee of the Pediatric Advisory Committee would be held on December 9, 2008. On page 67525, in the third column, the third sentence of the Procedure portion of the document is changed to read as follows:
Oral presentations from the public will be scheduled between approximately 11 a.m. to 12 noon on December 9, 2008.
This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: November 21, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E828382 Filed 112608; 8:45 am]
BILLING CODE 416001S
FOR FURTHER INFORMATION CONTACT
Carlos Pe[ntilde]a, Office of Science and Health Coordination, Office of the Commissioner (HF33), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301827 3340, email: carlos.pe[ntilde]a@fda.hhs.gov, or FDA Advisory Committee Information Line, 18007418138 (3014430572 in the Washington, DC area), code 8732310001. Please call the Information Line for uptodate information on this meeting.